Insider · CIK 0001985547

Ma Songjiang

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001985547

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-05-28	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−558 sh	$10.07	−$5,619.06	2,806,084
2025-05-27	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.28	−$20.6K	2,806,642
2025-05-23	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−182 sh	$10.24	−$1,863.68	2,808,642
2025-05-22	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.97	−$21.9K	2,808,824
2025-05-21	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.83	−$21.7K	2,810,824
2025-05-20	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.25	−$22.5K	2,812,824
2025-05-19	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.11	−$22.2K	2,814,824
2025-05-16	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.31	−$22.6K	2,816,824
2025-05-15	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.68	−$21.4K	2,818,824
2025-05-14	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−20 sh	$11.30	−$226	2,820,824
2025-05-13	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.37	−$22.7K	2,820,844
2025-05-12	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.56	−$21.1K	2,822,844
2025-03-21	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−174 sh	$10.00	−$1,740	2,824,844
2025-03-20	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.09	−$20.2K	2,825,018
2025-03-19	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.13	−$20.3K	2,827,018
2025-03-18	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−242 sh	$10.24	−$2,478.08	2,829,018
2025-03-17	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.09	−$24.2K	2,829,260
2025-03-14	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.31	−$24.6K	2,831,260
2025-03-13	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.80	−$23.6K	2,833,260
2025-03-12	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.74	−$23.5K	2,835,260
2025-03-11	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.40	−$22.8K	2,837,260
2025-03-10	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.14	−$20.3K	2,839,260
2025-03-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−53 sh	$13.03	−$690.59	2,843,207
2025-03-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−41 sh	$12.14	−$497.74	2,843,166
2025-03-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−1,906 sh	$10.13	−$19.3K	2,841,260
2025-03-06	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.80	−$21.6K	2,843,260
2025-03-05	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.98	−$22K	2,845,260
2025-03-04	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$10.86	−$21.7K	2,847,260
2025-03-03	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.23	−$22.5K	2,849,260
2025-02-28	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.41	−$22.8K	2,851,260
2025-02-27	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.33	−$22.7K	2,853,260
2025-02-26	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.63	−$23.3K	2,855,260
2025-02-25	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.37	−$22.7K	2,857,260
2025-02-24	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−1,813 sh	$10.60	−$19.2K	2,859,447
2025-02-24	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−187 sh	$11.52	−$2,154.24	2,859,260
2025-02-21	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−1,818 sh	$11.84	−$21.5K	2,861,442
2025-02-21	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−182 sh	$12.60	−$2,293.2	2,861,260
2025-02-20	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.40	−$24.8K	2,863,260
2025-02-19	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.29	−$24.6K	2,865,260
2025-02-18	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.49	−$25K	2,867,260
2025-02-14	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.94	−$23.9K	2,869,260
2025-02-13	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.69	−$23.4K	2,871,260
2025-02-12	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.49	−$23K	2,873,260
2025-02-11	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−1,878 sh	$11.52	−$21.6K	2,875,260
2025-02-10	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.90	−$23.8K	2,877,138
2025-02-07	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.16	−$24.3K	2,879,158
2025-02-06	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$12.85	−$25.7K	2,881,138
2025-02-05	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−1,980 sh	$12.39	−$24.5K	2,883,158
2025-02-05	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−20 sh	$12.84	−$256.8	2,883,138
2025-02-04	GYREGYRE THERAPEUTICS, INC.S Sale	Director, President	SSale	−2,000 sh	$11.62	−$23.2K	2,885,138

Recent filings

Accepted (ET)
May 294
Ma Songjiang0001140361-25-020754
SEC(opens sec.gov)
May 274
Ma Songjiang0001140361-25-020474
SEC(opens sec.gov)
May 224
Ma Songjiang0001140361-25-020156
SEC(opens sec.gov)
May 204
Ma Songjiang0001140361-25-019893
SEC(opens sec.gov)
May 164
Ma Songjiang0001140361-25-019468
SEC(opens sec.gov)
May 144
Ma Songjiang0001140361-25-018927
SEC(opens sec.gov)
Mar 254
Ma Songjiang0001140361-25-010234
SEC(opens sec.gov)
Mar 214
Ma Songjiang0001140361-25-009877
SEC(opens sec.gov)
Mar 194
Ma Songjiang0001140361-25-009424
SEC(opens sec.gov)
Mar 174
Ma Songjiang0001140361-25-009017
SEC(opens sec.gov)
Mar 134
Ma Songjiang0001140361-25-008623
SEC(opens sec.gov)

Companies

GYRE THERAPEUTICS, INC.Director, PresidentGYRE

Address

C/O GYRE THERAPEUTICS, INC. 12770 HIGH BLUFF DRIVE, SUITE 150

SAN DIEGO, CA, 92130